Duloxetine, Vigabatrin, Vortioxetine, Zonisamide, Avanafil, Dapoxetine, Sildenafil Citrate, Tadalafil, Vardenafil, Glibenclamide, Linagliptin, Lansoprazole API/Pellet, Omeprazole API/Pellet, Vonoprazan Fumarate

Product Description

Ultratech India Limited is a 30 year old transnational company specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs) and a diverse range of branded generic Finished Dosage Forms (FDFs) at its cGMP certified state-of-the-art manufacturing facilities in India, with a global presence.

We manufactures approximately 60 APIs and its key products are Trimetazidine, Fluconazole, Salbutamol, Glibenclamide, Vardenafil, Sildenafil, Tadalafil, Formoterol, Salmeterol, Ezetimibe, Oseltamivir, Bilastine, Vonoprazan, Nebivolol, Gadobutrol, Tetraxetan, Gadoterate, Dabigatran, Solifenacin, Vigabatrin, Dorzolamide, Valganciclovir, and Rivaroxaban, Vortioxetine, Voriconazole,etc

Ultratech, with its base in India and Europe, delivers its products to global pharmaceutical markets, supported by comprehensive documentation including DMFs, CTD dossiers, FSCs, & COPPs, and holds registrations in Russia, the EU, Latin America, Brazil, and Southeast Asian Countries.

Ultratech India Limited

IN
2015

On CPHI since
2

Certificates
100 - 249

Employees

Company types

Manufacturer/Innovator

Primary activities

API Producer

Compare Add to favorites Added to favorites

Specifications

Details

Anti Depressant / Anticonvulsant, Erectile Dysfunction, Anti Diabetic, Gastrointestinal
Selling Points
Anti-Allergens; Cardiovascular Health; Digestive Health; International Approvals/Standards; Product Features; Quality Service; The company's branded generic FDF portfolio includes over 300 drugs across a variety of therapeutic segments, including Cardiology, Diabetology, Antibiotics, Analgesics, Antineoplastics, Respiratory, Anti-Malarial, Gynaecology, Paediatrics, Nutraceuticals, and Health Supplements. Its FDFs product portfolio spans conventional dosage forms such as tablets, capsules, and injections, as well as advanced delivery systems like Pressurized Metered Dose Inhalers (pMDIs) and Dry Powder Inhalers (DPIs).

The company has state-of-the-art manufacturing infrastructure supported with a well-equipped R&D unit.
The company also offers CDMO (Contract Development and Manufacturing Organization) services, custom synthesis for small molecule drug substances, process development, and contract manufacturing for both Bulk APIs and Pharmaceutical Finished Dosage Forms.
Model

API
Supplied from

India
Measured In
kilogram